Aerobic Vaginitis (AV) Testing Now Available At BioReference Laboratories

BioReference Laboratories, Inc., along with its specialty women’s health division, GenPath, today announces the launch of new testing for aerobic vaginitis (AV).

BioReference Laboratories to Present at ACOG 2019, Demonstrating Commitment to the Research of Hereditary Conditions

ELMWOOD PARK, N.J., May 2, 2019 – BioReference Laboratories, Inc., an OPKO Health Company, along with its women’s health division GenPath, today announced the presentation of new research from its prenatal and hereditary cancer assessment programs at the 2019 American College of Obstetricians and Gynecologists (ACOG) Annual Meeting in Nashville, Tennessee from May 3-6. The […]

OPKO’s BioReference Laboratories Selected for UnitedHealthcare’s Preferred Lab Network

ELMWOOD PARK, NJ, April 22, 2019 – BioReference Laboratories Inc., an OPKO Health Company (NYSE:OPK), is pleased to announce it will gain preferred laboratory network provider status for UnitedHealthcare. The contract includes BioReference’s subsidiary GeneDx, a full service genetics laboratory.  Learn about the UnitedHealthcare Preferred Lab Network here. “At BioReference we are committed to making […]

BioReference Laboratories Recognized by Forbes as One of the Best Large Employers of 2019

Laboratory Employees Anonymously Select BioReference amongst 500 Other Large Companies ELMWOOD PARK, NJ, April 17, 2019 (GLOBE NEWSWIRE) — BioReference Laboratories, Inc., an OPKO Health Company (NYSE:OPK), is pleased to announce it has been recognized by Forbes as one of America’s Best Large Employers of 2019. This list includes 500 large companies, and BioReference is one […]

GeneDx Joins Rare Disease Organizations to Support Rare Disease Day 2019

Employees Nationwide Participate in Rare Disease Day Virtual Race Campaign GAITHERSBURG, Md., Feb 28, 2019 (GLOBE NEWSWIRE) –  GeneDx, Inc., a subsidiary of OPKO Health, Inc.’s BioReference Laboratories, Inc. and recognized leader in genetic testing, joins the worldwide rare disease community in honoring Rare Disease Day 2019 by participating in the fourth annual Rare Disease Day Virtual […]

Posted in Uncategorized

BioReference Laboratories Supports Federal Employees Amidst Government Shutdown

ELMWOOD PARK, Jan. 28, 2019 – BioReference Laboratories Inc., an OPKO Health Company, today announced that they will offer flexible payment arrangements for federal employees affected by the government shutdown. “We recognize the challenging financial position that federal government employees have faced throughout the shutdown,” said Jon R. Cohen, M.D., Executive Chairman of BioReference Laboratories. “While the […]

Posted in Uncategorized

OPKO Health Appoints Jon R. Cohen, M.D. Executive Chairman of BioReference Laboratories

Geoff Monk promoted to President MIAMI, Jan. 07, 2019 – OPKO Health, Inc. (NASDAQ: OPK) today announced the appointment of Jon R. Cohen, M.D. as Executive Chairman of BioReference Laboratories. BioReference, with its GeneDx unit, is the third largest clinical laboratory in the United States. OPKO also announced the promotion of Geoff Monk to President of BioReference.  Mr. Monk joined BioReference as General Manager […]

BioReference Laboratories Named as Preferred Laboratory with Horizon Healthcare Services Serving Members of Horizon Healthcare Services, Inc.

MIAMI, FL NOVEMBER 8, 2018 — BioReference Laboratories, Inc. (BRL), an OPKO Health company and the third largest clinical laboratory in the United States, will remain an in-network provider with Horizon Health Services, Inc. (Horizon), New Jersey’s oldest and largest health insurer. After an extensive evaluation of its laboratory network, BRL will remain a preferred laboratory in the Horizon PPO network. The […]

OPKO Plans to Address Draft Local Coverage Determination Published by Novitas Solutions for 4Kscore Test

MIAMI, May 18, 2018 (GLOBE NEWSWIRE) — OPKO Health, Inc.(Nasdaq:OPK) today announced that Novitas Solutions, Inc. issued a draft local coverage determination (LCD) for the 4Kscore test®. The draft LCD is a proposed non-coverage policy for the 4Kscore test for Medicare and, prior to its effectiveness, is subject to a public comment period ending July 5, 2018.  OPKO plans to submit comments during […]

OPKO Health Appoints Geoff Monk General Manager at BioReference Laboratories

MIAMI, May 01, 2018 (GLOBE NEWSWIRE) — OPKO Health, Inc.(NASDAQ:OPK) today announced the appointment of Geoff Monkas General Manager with overall responsibility for BioReference Laboratories (BRL), an OPKO Health company and the third largest clinical laboratory in the United States. Mr. Monk brings to BRL more than 20 years of operational, business strategy and technical experience.  Previously, Mr. Monk worked as Managing Director of […]